APGE

Apogee Therapeutics (APGE)

About Apogee Therapeutics (APGE)

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Details

Daily high

$77.50

Daily low

$74.52

Price at open

$75.40

52 Week High

$78.15

52 Week Low

$26.20

Market cap

4.6B

Dividend yield

0.00%

Volume

1.1M

Avg. volume

814,180

P/E ratio

-17.79

Apogee Therapeutics News